• Kazunori Kasama, Wilfred Mui, Wei Jei Lee, Muffazal Lakdawala, Takeshi Naitoh, Yosuke Seki, Akira Sasaki, Go Wakabayashi, Iwao Sasaki, Isao Kawamura, Lilian Kow, Harry Frydenberg, Anton Chen, Mahendra Narwaria, and Pradeep Chowbey.
• Weight Loss and Metabolic Surgery Center, Yotsuya Medical Cube, Tokyo, Japan. surgery@beige.ocn.ne.jp
• Obes Surg. 2012 May 1; 22 (5): 677-84.

AbstractAssociations of BMI with body composition and health outcomes may differ between Asian and European populations. Asian populations have also been shown to have an elevated risk of type 2 diabetes, hypertension, and hyperlipidemia at a relatively low level of BMI. New surgical indication for Asian patients should be discussed by the expert of this field. Forty-four bariatric experts in Asia-Pacific and other regions were chosen to have a voting privilege for IFSO-APC Consensus at the 2nd IFSO-APC Congress. A computerized audience-response voting system was used to analyze the agreement with the sentence of the consensus. Of all delegates, 95% agreed with the necessity of the establishment of IFSO-APC consensus statements, and 98% agreed with the necessity of a new indication for Asian patients. IFSO-APC Consensus statements 2011. Bariatric surgery should be considered for the treatment of obesity for acceptable Asian candidates with BMI ≥ 35 with or without co-morbidities. Bariatric/GI metabolic surgery should be considered for the treatment of T2DM or metabolic syndrome for patients who are inadequately controlled by lifestyle alternations and medical treatment for acceptable Asian candidates with BMI ≥ 30. The surgical approach may be considered as a non-primary alternative to treat inadequately controlled T2DM, or metabolic syndrome, for suitable Asian candidates with BMI ≥ 27.5. Other eight sentences are agreed with by majority of the voting delegates to form IFSO-APC consensus statements. This will help to make safe and wholesome the progress of bariatric and metabolic surgery in Asia.

20 keywords...

hide…